Tumor-targeted delivery of HSV-TK mRNA by charge-reversal LNP inhibits metastatic melanoma
Year: 2026
Type: article
Abstract: With bystander effect and tumor specificity, the Herpes Simplex Virus-Thymidine kinase (HSV-TK)/Ganciclovir (GCV) system is a powerful suicide gene therapy against cancers, including melanoma. Both viral and non-viral vectors have been used to deliver HSV-TK DNA. Previous studies revealed that tissue-specific delivery of mRNAs by non-viral vectors is a highly effective and safer approach for the expression of therapeutic proteins. Herein, we report targeted delivery of mRNA encoding HSV-TK to melanoma with metastasis by a ligand-functionalized lipid nanoparticle (LNP) containing an ionizable and charge-reversal lipid. Screening of a library of newly synthesized lipids containing an ester group at the terminus of the lipid chain identified Glu4 as the most effective RNA-binding lipid with the prompt charge reversal via hydrolysis of the end-group ester bond. Incorporation of adenosine-conjugated lipid (Ad4-DoGo4) into Glu4 resulted in a tumor-enriched LNP (denoted by GA3 LNP) with highly effective mRNA delivery in B16-F10 tumor and its metastasis. The delivery of HSV-TK mRNA by GA3 LNP, combined with co-administration of GCV, significantly inhibited both tumor growth and pulmonary metastasis. Collectively, our findings demonstrate that GA3 LNP represents a promising carrier for the tumor-targeted delivery of therapeutic mRNA.
Institutions: Inner Mongolia Medical University, Inner Mongolia University
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $2,590
OpenAlex ID: W7229797242
